Hypothesis of double polarization

Journal of the Neurological Sciences

Volumn 275, Issue 1-2, 2008, Pages 33-36

  Li, Jun ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axon; Axonal degeneration; Axonal transport; Charcot Marie Tooth disease; Intracellular trafficking; Myelin; Myelination; Oligodendrocyte; Paranodal loop; Schmidt Lanterman incisure; Schwann cell

Indexed keywords

ARTICLE; CELL MEMBRANE TRANSPORT; GENE MUTATION; GLIA CELL; HUMAN; MYELIN SHEATH; MYELINATION; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; OLIGODENDROGLIA; POLARIZATION; PRIORITY JOURNAL; SCHWANN CELL;

HUMANS; NERVOUS SYSTEM DISEASES; NEUROGLIA; NEURONS;

EID: 55649101859     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.07.009     Document Type: Article

References (39)

1. Sivakumar K., et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 128 (2005) 2304-2314
2. Quattrone A., et al. Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. Neurology 46 (1996) 1318-1324
3. Salzer J.L. Polarized domains of myelinated axons. Neuron 40 (2003) 297-318
4. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27 (2004) 723-749
5. Krajewski K.M., et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123 Pt 7 (2000) 1516-1527
6. Bjartmar C., Wujek J.R., and Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci. 206 (2003) 165-171
7. Friede R.L., and Bischhausen R. The precise geometry of large internodes. J Neurol.Sci 48 (1980) 367-381
8. Avila R.L., et al. Structure and stability of internodal myelin in mouse models of hereditary neuropathy. . J Neuropathol Exp Neurol 64 (2005) 976-990
9. Larocca J.N., and Rodriguez-Gabin A.G. Myelin biogenesis: vesicle transport in oligodendrocytes. Neurochem Res 27 (2002) 1313-1329
10. Lippincott-Schwartz J., Roberts T.H., and Hirschberg K. Secretory protein trafficking and organelle dynamics in living cells. Annu Rev Cell Dev Biol 16 (2000) 557-589
11. Scherer S.S., and Arroyo E.J. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7 (2002) 1-12
12. Blakemore W.F. Schmidt-Lantermann incisures in the central nervous system. J Ultrastruct Res 29 (1969) 496-498
13. Hall S.M., and Williams P.L. Some observations on the Schmidt-Lantermann incisures in peripheral mammalian nerve. J Anat 105 (1969) 215
14. Hall S.M., and Williams P.L. Studies on the "incisures" of Schmidt and Lanterman. J Cell Sci 6 (1970) 767-791
15. Court F.A., et al. Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431 (2004) 191-195
16. Griffiths I.R., et al. Expression of myelin protein genes in Schwann cells. J Neurocytol 18 (1989) 345-352
17. Richter-Landsberg C. Organization and functional roles of the cytoskeleton in oligodendrocytes. Microsc Res Tech 52 (2001) 628-636
18. Gould R.M., and Mattingly G. Regional localization of RNA and protein metabolism in Schwann cells in vivo. J Neurocytol 19 (1990) 285-301
19. Trapp B.D., et al. Polarization of myelinating Schwann cell surface membranes: role of microtubules and the trans-Golgi network. J Neurosci 15 (1995) 1797-1807
20. Benjamins J.A., and Nedelkoska L. Maintenance of membrane sheets by cultured oligodendrocytes requires continuous microtubule turnover and Golgi transport. Neurochem Res 19 (1994) 631-639
21. Buchthal F., Carlsen F., and Behse F. Schmidt-Lanterman clefts: a morphometric study in human sural nerve. Am J Anat 180 (1987) 156-160
22. Baumann N., and Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81 (2001) 871-927
23. Trapp B.D., Andrews S.B., Cootauco C., and Quarles R. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol 109 (1989) 2417-2426
24. Lucchinetti C.F., Bruck W., and Lassmann H. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56 (2004) 308
25. Senderek J., et al. X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations (1). J Neurol Sci 167 (1999) 90-101
26. Li J., et al. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration. J Comp Neurol 498 (2006) 252-265
27. Ludwin S.K., and Johnson E.S. Evidence for a "dying-back" gliopathy in demyelinating disease. Ann Neurol 9 (1981) 301-305
28. Bouldin T.W., Samsa G., Earnhardt T.S., and Krigman M.R. Schwann cell vulnerability to demyelination is associated with internodal length in tellurium neuropathy. J Neuropathol Exp Neurol 47 (1988) 41-47
29. Martini R. The effect of myelinating Schwann cells on axons. Muscle Nerve 24 (2001) 456-466
30. de Waegh S.M., Lee V.M., and Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68 (1992) 451-463
31. de Waegh S., and Brady S.T. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 10 (1990) 1855-1865
32. Watson D.F., Nachtman F.N., Kuncl R.W., and Griffin J.W. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot-Marie-Tooth disease type 1. Neurology 44 (1994) 2383-2387
33. Sahenk Z., Chen L., and Mendell J.R. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 45 (1999) 16-24
34. Hoke A., Gordon T., Zochodne D.W., and Sulaiman O.A. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol 173 (2002) 77-85
35. Keswani S.C., et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 56 (2004) 815-826
36. Garbern J.Y., et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125 (2002) 551-561
37. Griffiths I., et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280 (1998) 1610-1613
38. Hanemann C.O., Gabreels-Festen A.A., and De Jonghe P. Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul Disord 11 (2001) 753-756
39. Hoke A., et al. Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci 26 (2006) 9646-9655